Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 18 Source: CRO
- €20 million turnover
-
€32.5 million
profit - 52 employees
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
- 3 more years available »
Ranking
By Turnover
(€20 million)- 883rd in Top Companies
- 95th in Health
By Employees
(52)- 829th in Top Companies
- 89th in Health
- 52
- €20 million
Employees
- Colm Healy Vice President}
Latest News
- Oct 21 Declan Ganley denies Donald Trump trying to swing lucrative 5G contract for Rivada
- Oct 21 Amarenco Solar borrows €12m to finance growth
- Oct 21 Timber lobby says ‘zero evidence’ of Government clearing licence backlog
- Oct 21 Brexit: UK and EU agree to intensify talks in rush for deal
- Oct 21 Paschal Donohoe expects ‘some kind’ of OECD digital tax agreement in 2021